Federal contractor profile
MARK CUBAN COST PLUS DRUG COMPANY, PBC
UEI N8P7MQ937WN7CAGE 9VYL8Company website ↗
Active
Small Business
Overview
- Legal name
- MARK CUBAN COST PLUS DRUG COMPANY, PBC
- Registered location
- DALLAS, TX, USA
- Website
- Company website ↗
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- Latest award activity
- May 8, 2026
Read company summary
MARK CUBAN COST PLUS DRUG COMPANY, PBC is associated with UEI N8P7MQ937WN7 and CAGE 9VYL8 in public federal records. AcornBids currently links 2 prime awards totaling $1.6M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325412 (Pharmaceutical Preparation Manufacturing). Its public SAM.gov registration lists DALLAS, TX, USA.
At a glance
Lifetime prime obligations$1.6M
Prime awards2
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- MARK CUBAN COST PLUS DRUG COMPANY, PBC
- UEI
- N8P7MQ937WN7
- CAGE
- 9VYL8
- Registered address
- 3015 TAYLOR ST, DALLAS, TX, 75226, USA
- Registration status
- Active
- Primary NAICS
- 325412 — Pharmaceutical Preparation Manufacturing
- SAM activation
- Feb 3, 2026
- Initial registration
- Apr 26, 2024
- Entity start
- Jun 4, 2018
- SAM updated
- Feb 3, 2026
- Registration expires
- Jan 31, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| W911SR26CA011MARK CUBAN COST PLUS DRUG COMPANY (MCCPDC) INTENDS TO GENERATE A CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DATA PACKAGE SUITABLE FOR AN FDA ABBREVIATED NEW DRUG APPLICATION… | Department of Defense | $1.4M | Apr 13, 2026 | Apr 12, 2028 |
| W911SR25CA006THIS CONTRACT IS FOR PROOF OF CONCEPT PRODUCTION OF DRUG SUBSTANCE STERILE SALINE AND STERILE WATER USING NONSTERILE SOURCE WATER MADE UNDER CURRENT GOOD MANUFACTURING PRACTICE… | Department of Defense | $205.9K | Jun 16, 2025 | Dec 15, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Feb 3, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Apr 26, 2024 |
| Entity start | Jun 4, 2018 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| ALEXANDER OSHMYANSKY | Government business | Contact method not published | SAM registration | Not available |
| ALEXANDER OSHMYANSKY | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325412 — Pharmaceutical Preparation Manufacturing
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
376 awards
207 awards
149 awards
132 awards
125 awards
104 awards
About MARK CUBAN COST PLUS DRUG COMPANY, PBC
What products and services appear in its federal awards?
Recorded award industries: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); 541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Recorded products and services: AC12 — NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH; AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT.
Examples from recent award records:
- MARK CUBAN COST PLUS DRUG COMPANY (MCCPDC) INTENDS TO GENERATE A CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DATA PACKAGE SUITABLE FOR AN FDA ABBREVIATED NEW DRUG APPLICATION…
- THIS CONTRACT IS FOR PROOF OF CONCEPT PRODUCTION OF DRUG SUBSTANCE STERILE SALINE AND STERILE WATER USING NONSTERILE SOURCE WATER MADE UNDER CURRENT GOOD MANUFACTURING PRACTICE…
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
3015 TAYLOR ST, DALLAS, Texas 75226, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
325412 — Pharmaceutical Preparation Manufacturing.
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Defense.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit